The Obscene Obstacles to Global Vaccine Distribution Aug 6, 2021 https://www.youtube.com/watch?v=thA_5jVQddM Lori Wallach, of Public Citizen’s Global Trade Watch, and Jayati Ghosh, economics professor at UMass Amherst, discuss how first world countries are protecting pharma companies’ exorbitant profits, at the expense of vaccinating people living in the Global South and thereby also endangering everyone in the world.
Here's a toolkit!! https://rethinktrade.org/toolkit/no-big-pharma-monopolies-on-covid-vaccines-or-treatments-wto-trips-waiver-now/
Pharma companies are restricting production - Jayati Ghosh.. many of the technology development has been funded or supported from public funds..
https://www.oxfam.org/en/press-releases/vaccine-monopolies-make-cost-vaccinating-world-against-covid-least-5-times-more 29th July 2021
https://www.gavi.org/covax-facility
https://www.gavi.org/vaccineswork/covax-explained
What is COVAX? COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.
https://www.gavi.org/sites/default/files/covid/covax/Gavi-COVAX-AMC-Investment-Opportunity.pdf
In times like these, global solidarity is key. We call on governments, manufacturers and the private
sector to ensure equitable access to supply and distribution of vaccines through COVAX so that no
one is left behind